Major Events of Beroni Group Limited in 2020
From January 29 to February 4, President of Beroni USA Mr. Linfeng Li came to Guang Zhou with “Virus Hunter” Professor Walter Ian Lipkin, helping prevent and control COVID-19 outbreak.…
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification
On December 21, 2020, Australia, Beroni Group Limited (“Beroni Group”) announces it has received notification from its European Authorized Representative, CMC Medical Devices & Drugs SL, that its newly developed…
Beilemei
Beroni Group Launches a New Probiotics Health Product in China
NEW YORK and SYDNEY, November 10, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development,…
Certificate
Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020
NEW YORK and SYDNEY, November 9, 2020 - Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise announced today that the Company has been…
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19
NEW YORK and SYDNEY, October 19, 2020, Beroni Group (“Beroni”) announced successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation (“GenScript”), a leading global biotechnology company.…
Group photo of Beroni Group and Genscript’s R&D teams
Beroni Group Collaborates with Genscript Biotech Corporation
On August 4, 2020, Beroni Group Limited (“Beroni Group”) announced that it has signed an agreement with GenScript Biotech Corporation (“Genscript”) to collaborate in the development of a medical solution…
Beroni Group to Supply COVID-19 Antibody Test Kit to Japan
On July 10, 2020, Beroni Group Limited (“Beroni”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases,…
Group photo of representatives of the two sides
Representatives of Huarong Securities Co., Ltd Visit Beroni Group
On 22nd May, the representatives of Huarong Securities Co., Ltd (“Huarong Securities”) including Mr. Minsheng Jian, General Manager of Enterprise Innovation Financing Department, Mr. Yuying Geng, General Manager of Business…
Mr. Jacky Zhang and Mr. Duo Zheng signing the cooperation agreement
Strategic Cooperation between Beroni Group and BG Health
On 13th May, 2020, Beroni Group Co., Ltd. (Beroni Group) and Beijing Health Industrial Investment Management Co., Ltd. (BG Health) signed a strategic cooperation agreement to collaborate in fields of…
This news has been highlighted in several online media sites
Beroni Group and Tianjin University have made a significant discovery in developing a medical solution using nanobody technology for the novel coronavirus
On May 11, 2020, Beroni Group is pleased to announce that its development of a medical solution using nanobody technology for the novel coronavirus (SARS-CoV-2), in collaboration with Tianjin University…